Tepnel Life Sciences plc of Manchester, UK has been awarded two grants to expand its pipeline of human diagnostic tests and grow its pharmaceutical services business in Scotland.
The first, a grant of GBP 50,000 from the Biotechnology and Biological Sciences Research Council (BBSRC) will support the development of epigenetic diagnostics. The award was made under the Industry Interchange Programme which seeks to promote the transfer of expertise between academic and commercial organisations.
The development of epigenetic technology will provide new and more efficient methods to screen for epigenetic changes that indicate both predisposition to and the development of disease. This will complement genotyping and other molecular services at Tepnel's facility, allowing researchers to investigate both epigenetic and genetic factors in disease.
The second grant, a business support award from Scottish Enterprise, Edinburgh and Lothians will be used for a Europe and the US marketing campaign to promote Tepnel’s services.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
